Biotechnology
The Biotechnology industry has a total of 587 stocks, with a combined market cap of $1.25 trillion and total revenue of $109.81 billion.
Market Cap
1.25T
Revenue
109.81B
Profits
-41.34B
PE Ratio
n/a
Profit Margin
-37.64%
Dividend Yield
0.04%
587 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 121.89B | -1.06% | 1,152,455 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 67.46B | -0.22% | 604,975 | 14.92B |
| 3 | ARGX | argenx SE | 54.18B | -0.16% | 380,224 | 4.74B |
| 4 | RVMD | Revolution Medicines, Inc. | 39.11B | -1.57% | 1,705,381 | - |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.46B | -3.58% | 2,682,653 | 4.29B |
| 6 | ONC | BeOne Medicines AG | 33.79B | 1.76% | 459,224 | 5.74B |
| 7 | RPRX | Royalty Pharma plc | 32.51B | 0.04% | 2,216,158 | 2.44B |
| 8 | MRNA | Moderna, Inc. | 26.59B | -1.85% | 8,521,960 | 2.23B |
| 9 | ROIV | Roivant Sciences Ltd. | 24.82B | -4.06% | 4,774,573 | 8.26M |
| 10 | INSM | Insmed Incorporated | 23.66B | -5.60% | 2,825,191 | 819.56M |
| 11 | INCY | Incyte Corporation | 22.82B | -2.12% | 1,481,000 | 5.36B |
| 12 | BNTX | BioNTech SE | 22.78B | -1.55% | 671,434 | 3.23B |
| 13 | GMAB | Genmab A/S | 17.82B | -0.69% | 4,555,493 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 16.47B | -1.93% | 601,056 | 998.25M |
| 15 | BBIO | BridgeBio Pharma, Inc. | 16.29B | -3.27% | 3,372,444 | 579.96M |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 14.89B | -2.81% | 838,412 | 4.44B |
| 17 | EXEL | Exelixis, Inc. | 14.09B | -0.81% | 2,844,297 | 2.38B |
| 18 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.24B | -1.06% | 287,876 | 1.13B |
| 19 | SMMT | Summit Therapeutics Inc. | 11.88B | 0.33% | 3,389,953 | - |
| 20 | ABVX | ABIVAX Société Anonyme | 11.80B | -2.80% | 1,034,379 | 5.67M |
| 21 | AXSM | Axsome Therapeutics, Inc. | 11.75B | -2.36% | 762,430 | 708.24M |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 11.44B | 0.14% | 1,587,086 | 3.24B |
| 23 | CYTK | Cytokinetics, Incorporated | 11.17B | -3.10% | 1,891,495 | 105.82M |
| 24 | TECH | Bio-Techne Corporation | 11.12B | 0.08% | 2,176,689 | 1.21B |
| 25 | KRYS | Krystal Biotech, Inc. | 10.71B | -0.65% | 378,785 | 417.30M |
| 26 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.44B | -3.00% | 2,481,755 | 622.01M |
| 27 | APGE | Apogee Therapeutics, Inc. | 10.03B | 0.13% | 1,209,076 | - |
| 28 | NUVL | Nuvalent, Inc. | 9.83B | 0.03% | 2,458,548 | - |
| 29 | IONS | Ionis Pharmaceuticals, Inc. | 9.38B | -2.58% | 5,097,825 | 1.06B |
| 30 | CORT | Corcept Therapeutics Incorporated | 9.22B | -6.51% | 1,325,306 | 769.10M |
| 31 | KYMR | Kymera Therapeutics, Inc. | 9.08B | -7.50% | 809,405 | 51.48M |
| 32 | HALO | Halozyme Therapeutics, Inc. | 9.03B | -0.12% | 1,822,524 | 1.51B |
| 33 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.82B | 0.11% | 6,258,260 | 18.07M |
| 34 | PRAX | Praxis Precision Medicines, Inc. | 8.77B | -3.21% | 237,397 | 7.46M |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 8.35B | -1.16% | 540,996 | 74.06M |
| 36 | SYRE | Spyre Therapeutics, Inc. | 8.24B | -4.10% | 1,038,819 | - |
| 37 | PCVX | Vaxcyte, Inc. | 8.23B | -2.03% | 831,065 | - |
| 38 | IBRX | ImmunityBio, Inc. | 8.16B | -5.23% | 9,894,898 | 140.98M |
| 39 | IMVT | Immunovant, Inc. | 7.95B | -2.54% | 806,418 | - |
| 40 | TGTX | TG Therapeutics, Inc. | 7.80B | -3.69% | 1,950,893 | 700.35M |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.37B | -0.84% | 420,774 | 217.17M |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | 7.26B | -2.53% | 600,989 | 569.61M |
| 43 | PTCT | PTC Therapeutics, Inc. | 6.75B | -4.15% | 984,879 | 827.11M |
| 44 | SRRK | Scholar Rock Holding Corporation | 6.55B | -3.54% | 1,675,568 | - |
| 45 | XENE | Xenon Pharmaceuticals Inc. | 6.55B | -1.74% | 1,527,395 | 7.50M |
| 46 | COGT | Cogent Biosciences, Inc. | 6.40B | -3.63% | 1,610,082 | - |
| 47 | CGON | CG Oncology, Inc. | 6.39B | -3.64% | 992,417 | 5.07M |
| 48 | LGND | Ligand Pharmaceuticals Incorporated | 6.13B | -2.21% | 245,691 | 274.48M |
| 49 | DFTX | Definium Therapeutics, Inc. | 5.79B | -7.27% | 1,799,832 | - |
| 50 | BLTE | Belite Bio, Inc | 5.78B | -1.54% | 194,553 | - |
| 51 | ERAS | Erasca, Inc. | 5.57B | -3.40% | 2,555,112 | - |
| 52 | DNTH | Dianthus Therapeutics, Inc. | 5.39B | 1.07% | 542,454 | 1.34M |
| 53 | TVTX | Travere Therapeutics, Inc. | 5.23B | -0.53% | 1,032,927 | 536.20M |
| 54 | ORKA | Oruka Therapeutics, Inc. | 5.10B | -2.57% | 769,769 | - |
| 55 | CELC | Celcuity Inc. | 5.06B | -3.52% | 1,256,367 | - |
| 56 | CRSP | CRISPR Therapeutics AG | 4.99B | -5.10% | 1,965,020 | 4.10M |
| 57 | LEGN | Legend Biotech Corporation | 4.98B | -4.91% | 2,983,105 | 1.14B |
| 58 | CAI | Caris Life Sciences, Inc. | 4.82B | 0.41% | 4,267,049 | 907.29M |
| 59 | MANE | Veradermics, Incorporated | 4.60B | -7.88% | 454,335 | - |
| 60 | EWTX | Edgewise Therapeutics, Inc. | 4.44B | -9.12% | 1,037,510 | - |
| 61 | VKTX | Viking Therapeutics, Inc. | 4.43B | -1.90% | 2,006,679 | - |
| 62 | ACAD | ACADIA Pharmaceuticals Inc. | 4.37B | -2.75% | 1,562,769 | 1.10B |
| 63 | DNLI | Denali Therapeutics Inc. | 4.20B | 3.12% | 1,894,426 | - |
| 64 | TNGX | Tango Therapeutics, Inc. | 4.10B | -8.69% | 2,503,163 | 56.99M |
| 65 | RLAY | Relay Therapeutics, Inc. | 4.08B | -6.40% | 2,370,921 | 10.68M |
| 66 | DYN | Dyne Therapeutics, Inc. | 3.91B | 0.94% | 1,884,700 | - |
| 67 | NAMS | NewAmsterdam Pharma Company N.V. | 3.89B | -5.62% | 486,050 | 22.57M |
| 68 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.85B | 0.03% | 3,385,986 | 596.96M |
| 69 | PBLS | Parabilis Medicines, Inc. | 3.77B | -3.07% | 640,727 | - |
| 70 | TLX | Telix Pharmaceuticals Limited | 3.72B | -1.53% | 139,360 | 803.79M |
| 71 | GPCR | Structure Therapeutics Inc. | 3.67B | -3.22% | 541,287 | - |
| 72 | ALMS | Alumis Inc. | 3.58B | -0.74% | 1,207,065 | 8.40M |
| 73 | ELVN | Enliven Therapeutics, Inc. | 3.55B | -0.43% | 600,100 | - |
| 74 | RCUS | Arcus Biosciences, Inc. | 3.53B | -2.94% | 954,764 | 236.00M |
| 75 | IDYA | IDEAYA Biosciences, Inc. | 3.44B | -2.27% | 653,425 | 225.27M |
| 76 | ARQT | Arcutis Biotherapeutics, Inc. | 3.39B | -2.24% | 1,439,069 | 415.62M |
| 77 | RARE | Ultragenyx Pharmaceutical Inc. | 3.26B | -1.77% | 1,394,253 | 670.00M |
| 78 | BEAM | Beam Therapeutics Inc. | 3.09B | -5.14% | 2,862,285 | 164.01M |
| 79 | CLDX | Celldex Therapeutics, Inc. | 3.02B | -1.48% | 660,161 | 865.00K |
| 80 | VERA | Vera Therapeutics, Inc. | 2.98B | -1.19% | 2,233,823 | - |
| 81 | IRON | Disc Medicine, Inc. | 2.90B | -0.80% | 496,296 | - |
| 82 | MBX | MBX Biosciences, Inc. | 2.86B | -1.65% | 643,341 | - |
| 83 | QURE | uniQure N.V. | 2.83B | -3.59% | 1,460,098 | 18.09M |
| 84 | KLRA | Kailera Therapeutics, Inc. | 2.59B | -3.43% | 525,349 | - |
| 85 | IMNM | Immunome, Inc. | 2.58B | -2.36% | 986,512 | 4.02M |
| 86 | KOD | Kodiak Sciences Inc. | 2.57B | -0.51% | 570,314 | - |
| 87 | TARS | Tarsus Pharmaceuticals, Inc. | 2.55B | 2.01% | 1,113,208 | 535.08M |
| 88 | SLS | SELLAS Life Sciences Group, Inc. | 2.48B | -1.10% | 5,171,561 | - |
| 89 | PHVS | Pharvaris N.V. | 2.45B | - | 286,655 | - |
| 90 | MLYS | Mineralys Therapeutics, Inc. | 2.43B | -2.78% | 830,820 | - |
| 91 | VCEL | Vericel Corporation | 2.43B | 1.04% | 432,209 | 292.09M |
| 92 | AGIO | Agios Pharmaceuticals, Inc. | 2.41B | -1.65% | 713,874 | 66.05M |
| 93 | NRIX | Nurix Therapeutics, Inc. | 2.36B | -1.52% | 1,550,879 | 36.77M |
| 94 | TRVI | Trevi Therapeutics, Inc. | 2.35B | -7.40% | 4,238,955 | - |
| 95 | NKTR | Nektar Therapeutics | 2.31B | -2.90% | 707,295 | 55.63M |
| 96 | BHVN | Biohaven Ltd. | 2.28B | -2.44% | 1,690,911 | - |
| 97 | ZLAB | Zai Lab Limited | 2.20B | -4.25% | 1,459,022 | 453.28M |
| 98 | OCUL | Ocular Therapeutix, Inc. | 2.16B | -3.14% | 1,437,607 | 52.04M |
| 99 | MESO | Mesoblast Limited | 2.11B | 5.05% | 342,604 | 65.38M |
| 100 | KARD | Kardigan, Inc. | 2.10B | -4.50% | 423,062 | - |
| 101 | VRDN | Viridian Therapeutics, Inc. | 2.10B | -3.80% | 1,198,571 | 70.92M |
| 102 | PVLA | Palvella Therapeutics, Inc. | 2.09B | 0.88% | 209,774 | - |
| 103 | ADMA | ADMA Biologics, Inc. | 2.08B | -1.21% | 2,874,364 | 509.86M |
| 104 | ANAB | AnaptysBio, Inc. | 2.07B | 5.15% | 840,523 | 232.39M |
| 105 | AUPH | Aurinia Pharmaceuticals Inc. | 2.06B | 1.58% | 1,322,454 | 298.30M |
| 106 | HRMY | Harmony Biosciences Holdings, Inc. | 2.06B | -3.53% | 669,607 | 899.11M |
| 107 | SNDX | Syndax Pharmaceuticals, Inc. | 2.03B | -3.05% | 1,422,906 | 217.17M |
| 108 | NBTX | Nanobiotix S.A. | 2.02B | -2.30% | 106,906 | 38.27M |
| 109 | NUVB | Nuvation Bio Inc. | 2.01B | -0.69% | 4,640,549 | 143.05M |
| 110 | ABCL | AbCellera Biologics Inc. | 1.99B | -4.12% | 4,059,690 | 79.21M |
| 111 | SRPT | Sarepta Therapeutics, Inc. | 1.99B | -0.69% | 2,457,686 | 2.18B |
| 112 | SION | Sionna Therapeutics, Inc. | 1.98B | -2.96% | 415,290 | - |
| 113 | LKFT | Lakefront Biotherapeutics NV | 1.98B | -1.55% | 156,907 | 1.20B |
| 114 | TYRA | Tyra Biosciences, Inc. | 1.94B | -0.24% | 642,100 | - |
| 115 | RAPP | Rapport Therapeutics, Inc. | 1.94B | -2.78% | 364,521 | 20.00M |
| 116 | URGN | UroGen Pharma Ltd. | 1.92B | 2.46% | 577,222 | 140.49M |
| 117 | GLUE | Monte Rosa Therapeutics, Inc. | 1.86B | -4.60% | 1,586,837 | 42.95M |
| 118 | BCAX | Bicara Therapeutics Inc. | 1.85B | -2.63% | 420,314 | - |
| 119 | COAG | Hemab Therapeutics Holdings, Inc. | 1.85B | 3.89% | 369,987 | - |
| 120 | PGEN | Precigen, Inc. | 1.84B | -2.82% | 3,042,611 | 31.60M |
| 121 | STOK | Stoke Therapeutics, Inc. | 1.83B | -6.12% | 580,457 | 32.08M |
| 122 | GENB | Generate Biomedicines, Inc. | 1.83B | -0.35% | 531,686 | 30.30M |
| 123 | ATAI | AtaiBeckley Inc. | 1.83B | -3.87% | 7,860,421 | 3.49M |
| 124 | NTLA | Intellia Therapeutics, Inc. | 1.82B | -8.44% | 7,478,707 | 66.09M |
| 125 | IOVA | Iovance Biotherapeutics, Inc. | 1.80B | -4.49% | 13,326,232 | 285.61M |
| 126 | ZYME | Zymeworks Inc. | 1.79B | -3.63% | 340,708 | 81.26M |
| 127 | ZBIO | Zenas BioPharma, Inc. | 1.76B | -2.99% | 857,088 | 10.00M |
| 128 | AAPG | Ascentage Pharma Group International | 1.76B | -1.85% | 3,367 | 82.08M |
| 129 | RXRX | Recursion Pharmaceuticals, Inc. | 1.75B | -7.30% | 24,497,736 | 66.41M |
| 130 | GHRS | GH Research PLC | 1.74B | -4.38% | 196,029 | - |
| 131 | ABSI | Absci Corporation | 1.73B | -3.68% | 2,925,498 | 1.84M |
| 132 | DMRA | Damora Therapeutics, Inc. | 1.72B | -1.86% | 269,776 | - |
| 133 | TSHA | Taysha Gene Therapies, Inc. | 1.72B | -15.14% | 6,443,772 | 7.47M |
| 134 | FTRE | Fortrea Holdings Inc. | 1.69B | 0.56% | 802,777 | 2.71B |
| 135 | MLTX | MoonLake Immunotherapeutics | 1.69B | 0.25% | 1,315,841 | - |
| 136 | MPLT | MapLight Therapeutics, Inc. | 1.66B | -6.99% | 511,492 | - |
| 137 | IMCR | Immunocore Holdings plc | 1.65B | 1.69% | 896,423 | 412.81M |
| 138 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.64B | 4.43% | 3,145,795 | 204.73M |
| 139 | VIR | Vir Biotechnology, Inc. | 1.64B | -2.41% | 1,914,217 | 65.50M |
| 140 | INVA | Innoviva, Inc. | 1.64B | -0.13% | 592,234 | 420.69M |
| 141 | MAZE | Maze Therapeutics, Inc. | 1.61B | -4.55% | 508,262 | 20.00M |
| 142 | AVBP | ArriVent BioPharma, Inc. | 1.57B | -0.15% | 327,924 | - |
| 143 | SEPN | Septerna, Inc. | 1.55B | -4.37% | 394,056 | 72.26M |
| 144 | NVAX | Novavax, Inc. | 1.47B | -4.50% | 3,855,077 | 596.34M |
| 145 | SVRA | Savara Inc. | 1.46B | -4.81% | 1,680,541 | - |
| 146 | AKTS | Aktis Oncology, Inc. | 1.41B | -8.27% | 667,386 | 8.28M |
| 147 | INBX | Inhibrx Biosciences, Inc. | 1.35B | -0.91% | 233,313 | 1.30M |
| 148 | ARDX | Ardelyx, Inc. | 1.27B | -2.65% | 2,929,399 | 427.68M |
| 149 | JBIO | Jade Biosciences, Inc. | 1.26B | 1.67% | 1,587,732 | - |
| 150 | IMTX | Immatics N.V. | 1.26B | -4.65% | 178,908 | 43.00M |
| 151 | MNKD | MannKind Corporation | 1.25B | -1.22% | 4,043,844 | 360.78M |
| 152 | CRVS | Corvus Pharmaceuticals, Inc. | 1.24B | -6.13% | 1,485,152 | - |
| 153 | AVLN | Avalyn Pharma Inc. | 1.23B | -0.78% | 247,500 | - |
| 154 | TRAX | First Tracks Biotherapeutics, Inc. | 1.22B | -3.39% | 965,823 | - |
| 155 | EYPT | EyePoint, Inc. | 1.20B | -2.99% | 1,122,270 | 7.61M |
| 156 | CAPR | Capricor Therapeutics, Inc. | 1.19B | -4.18% | 1,275,598 | 11.13M |
| 157 | WVE | Wave Life Sciences Ltd. | 1.14B | -4.80% | 2,411,085 | 71.80M |
| 158 | MGTX | MeiraGTx Holdings plc | 1.14B | -7.84% | 1,727,775 | 79.76M |
| 159 | XNCR | Xencor, Inc. | 1.11B | -5.62% | 662,541 | 97.36M |
| 160 | DRTS | Alpha Tau Medical Ltd. | 1.10B | -4.17% | 706,382 | - |
| 161 | CGEM | Cullinan Therapeutics, Inc. | 1.10B | -1.43% | 651,881 | - |
| 162 | SANA | Sana Biotechnology, Inc. | 1.09B | -5.45% | 2,467,739 | - |
| 163 | ORIC | ORIC Pharmaceuticals, Inc. | 1.08B | -3.59% | 888,917 | - |
| 164 | FBRX | Forte Biosciences, Inc. | 1.08B | 0.46% | 742,648 | - |
| 165 | SPTX | Seaport Therapeutics, Inc. | 1.08B | -6.86% | 63,234 | - |
| 166 | OLMA | Olema Pharmaceuticals, Inc. | 1.04B | -0.50% | 1,226,607 | - |
| 167 | IVA | Inventiva S.A. | 1.01B | - | 735,102 | 7.94M |
| 168 | AVTX | Avalo Therapeutics, Inc. | 994.01M | -1.56% | 698,842 | 59.00K |
| 169 | JANX | Janux Therapeutics, Inc. | 984.29M | -1.59% | 801,070 | 13.73M |
| 170 | ANRO | Alto Neuroscience, Inc. | 983.68M | 5.85% | 2,147,379 | - |
| 171 | VOR | Vor Biopharma Inc. | 976.97M | -5.80% | 1,107,755 | - |
| 172 | KURA | Kura Oncology, Inc. | 968.53M | -4.72% | 1,579,693 | 71.64M |
| 173 | LXRX | Lexicon Pharmaceuticals, Inc. | 963.91M | -2.25% | 1,705,614 | 69.64M |
| 174 | SLDB | Solid Biosciences Inc. | 956.93M | -6.72% | 1,193,066 | - |
| 175 | PHAR | Pharming Group N.V. | 950.15M | -0.65% | 11,753 | 369.49M |
| 176 | DBVT | DBV Technologies S.A. | 948.71M | -3.09% | 129,643 | 5.74M |
| 177 | LBRX | LB Pharmaceuticals Inc | 924.82M | -2.12% | 135,228 | - |
| 178 | ANNX | Annexon, Inc. | 922.43M | -2.93% | 3,040,205 | - |
| 179 | ABUS | Arbutus Biopharma Corporation | 921.51M | -2.81% | 1,350,251 | 191.45M |
| 180 | GERN | Geron Corporation | 910.96M | -5.33% | 7,162,276 | 196.12M |
| 181 | TBPH | Theravance Biopharma, Inc. | 875.90M | -0.18% | 777,039 | 109.78M |
| 182 | PHAT | Phathom Pharmaceuticals, Inc. | 866.98M | -13.44% | 1,837,439 | 204.89M |
| 183 | DSGN | Design Therapeutics, Inc. | 865.34M | -8.79% | 654,555 | - |
| 184 | FTH | Faeth Therapeutics, Inc. | 859.98M | -7.74% | 542,553 | - |
| 185 | ODTX | Odyssey Therapeutics, Inc. | 843.13M | 5.51% | 330,309 | 1.06M |
| 186 | REPL | Replimune Group, Inc. | 834.00M | -9.60% | 2,829,991 | - |
| 187 | TENX | Tenax Therapeutics, Inc. | 816.45M | -8.95% | 1,299,236 | - |
| 188 | CTMX | CytomX Therapeutics, Inc. | 805.50M | -1.60% | 3,314,274 | 35.54M |
| 189 | OCS | Oculis Holding AG | 794.10M | -3.52% | 302,549 | 1.40M |
| 190 | ZVRA | Zevra Therapeutics, Inc. | 779.14M | -1.27% | 868,206 | 122.29M |
| 191 | AURA | Aura Biosciences, Inc. | 772.10M | 2.34% | 597,320 | - |
| 192 | SPRY | ARS Pharmaceuticals, Inc. | 768.61M | -2.52% | 1,399,972 | 98.99M |
| 193 | ACRS | Aclaris Therapeutics, Inc. | 768.15M | -1.43% | 1,087,870 | 8.37M |
| 194 | RIGL | Rigel Pharmaceuticals, Inc. | 764.14M | -2.94% | 430,633 | 299.77M |
| 195 | NGNE | Neurogene Inc. | 763.60M | -3.31% | 235,703 | 925.00K |
| 196 | CLYM | Climb Bio, Inc. | 756.41M | -5.64% | 1,235,984 | - |
| 197 | IMMX | Immix Biopharma, Inc. | 748.92M | -5.31% | 1,250,245 | - |
| 198 | DRUG | Bright Minds Biosciences Inc. | 730.11M | -2.45% | 389,928 | - |
| 199 | OMER | Omeros Corporation | 724.48M | -2.63% | 1,220,291 | 9.89M |
| 200 | GYRE | Gyre Therapeutics, Inc. | 706.84M | -2.76% | 65,810 | 117.05M |
| 201 | CADL | Candel Therapeutics, Inc. | 706.33M | 1.58% | 1,627,536 | - |
| 202 | SLBT | SL Science Holding Limited | 699.84M | -8.46% | 36,945 | - |
| 203 | MNPR | Monopar Therapeutics Inc. | 692.18M | -3.07% | 214,641 | - |
| 204 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 682.51M | 2.40% | 495,280 | - |
| 205 | RLMD | Relmada Therapeutics, Inc. | 676.54M | 0.62% | 2,145,380 | - |
| 206 | ALLO | Allogene Therapeutics, Inc. | 666.15M | -3.50% | 8,941,782 | 22.00K |
| 207 | SGP | SpyGlass Pharma, Inc. | 665.32M | -11.63% | 221,478 | - |
| 208 | RGNX | REGENXBIO Inc. | 659.16M | -8.60% | 2,184,641 | 87.82M |
| 209 | CRMD | CorMedix Inc. | 652.72M | -0.95% | 886,079 | 400.05M |
| 210 | TECX | Tectonic Therapeutic, Inc. | 647.97M | -0.09% | 150,120 | - |
| 211 | PRME | Prime Medicine, Inc. | 634.87M | -7.01% | 3,550,485 | 4.03M |
| 212 | ACHV | Achieve Life Sciences, Inc. | 626.22M | -0.16% | 1,327,459 | - |
| 213 | MDXG | MiMedx Group, Inc. | 607.70M | -0.73% | 1,235,219 | 389.42M |
| 214 | AGMB | AgomAb Therapeutics NV | 606.24M | -5.89% | 116,204 | - |
| 215 | DNA | Ginkgo Bioworks Holdings, Inc. | 591.19M | -0.44% | 655,140 | 151.40M |
| 216 | FDMT | 4D Molecular Therapeutics, Inc. | 590.72M | -8.20% | 632,263 | 88.24M |
| 217 | ALT | Altimmune, Inc. | 581.48M | -1.97% | 2,457,098 | 36.00K |
| 218 | NVCT | Nuvectis Pharma, Inc. | 581.33M | 0.49% | 175,460 | - |
| 219 | EIKN | Eikon Therapeutics, Inc. | 565.21M | -1.32% | 191,150 | - |
| 220 | CTNM | Contineum Therapeutics, Inc. | 546.59M | -3.75% | 261,009 | - |
| 221 | ASMB | Assembly Biosciences, Inc. | 534.27M | -1.61% | 112,993 | 71.10M |
| 222 | ARVN | Arvinas, Inc. | 522.62M | -2.06% | 678,236 | 89.40M |
| 223 | CBIO | Crescent Biopharma, Inc. | 521.36M | -9.52% | 121,206 | 11.88M |
| 224 | XOMA | XOMA Royalty Corporation | 503.77M | -9.16% | 6,711,917 | 48.56M |
| 225 | RZLT | Rezolute, Inc. | 495.17M | -0.21% | 2,446,462 | - |
| 226 | STTK | Shattuck Labs, Inc. | 493.06M | -3.16% | 863,437 | 1.00M |
| 227 | VALN | Valneva SE | 490.82M | 4.16% | 18,127 | 180.25M |
| 228 | ZURA | Zura Bio Limited | 489.24M | 0.78% | 1,181,101 | - |
| 229 | PROK | ProKidney Corp. | 486.32M | -8.52% | 2,048,282 | 889.00K |
| 230 | EDIT | Editas Medicine, Inc. | 484.94M | -3.07% | 2,067,683 | 38.69M |
| 231 | OCGN | Ocugen, Inc. | 477.32M | -4.08% | 5,548,395 | 4.47M |
| 232 | KYTX | Kyverna Therapeutics, Inc. | 472.38M | -8.48% | 1,963,190 | - |
| 233 | VSTM | Verastem, Inc. | 471.88M | -2.89% | 2,416,670 | 49.59M |
| 234 | PRTA | Prothena Corporation plc | 462.28M | -4.44% | 781,723 | 57.94M |
| 235 | STRO | Sutro Biopharma, Inc. | 461.32M | -6.36% | 210,738 | 99.61M |
| 236 | OVID | Ovid Therapeutics Inc. | 453.54M | -3.57% | 1,147,843 | 7.12M |
| 237 | CABA | Cabaletta Bio, Inc. | 450.85M | -7.06% | 4,319,298 | - |
| 238 | BNTC | Benitec Biopharma Inc. | 446.26M | -3.20% | 85,501 | - |
| 239 | SGMT | Sagimet Biosciences Inc. | 441.53M | -2.99% | 917,544 | - |
| 240 | PRLD | Prelude Therapeutics Incorporated | 440.35M | -7.60% | 320,589 | 16.72M |
| 241 | SLN | Silence Therapeutics plc | 438.80M | 2.20% | 233,567 | 839.00K |
| 242 | EVMN | Evommune, Inc. | 435.82M | -8.40% | 499,897 | 10.00M |
| 243 | ARTV | Artiva Biotherapeutics, Inc. | 433.89M | -7.37% | 434,691 | 251.00K |
| 244 | CCCC | C4 Therapeutics, Inc. | 433.42M | -3.45% | 3,013,299 | 34.86M |
| 245 | EPRX | Eupraxia Pharmaceuticals Inc. | 420.02M | -3.74% | 189,886 | - |
| 246 | HELP | Cybin Inc. | 415.29M | -2.47% | 2,073,059 | - |
| 247 | PBYI | Puma Biotechnology, Inc. | 411.27M | 1.00% | 293,397 | 227.18M |
| 248 | CMPX | Compass Therapeutics, Inc. | 407.00M | -3.00% | 1,879,366 | 850.00K |
| 249 | RCKT | Rocket Pharmaceuticals, Inc. | 406.20M | -4.86% | 1,719,937 | - |
| 250 | DMAC | DiaMedica Therapeutics Inc. | 403.59M | -2.35% | 168,099 | - |
| 251 | ABEO | Abeona Therapeutics Inc. | 399.54M | 0.43% | 1,449,744 | 14.54M |
| 252 | IPSC | Century Therapeutics, Inc. | 396.78M | -2.22% | 1,712,019 | 109.16M |
| 253 | ENTA | Enanta Pharmaceuticals, Inc. | 396.63M | -0.44% | 139,399 | 69.21M |
| 254 | UPB | Upstream Bio, Inc. | 396.18M | -3.32% | 266,131 | 3.32M |
| 255 | AUTL | Autolus Therapeutics plc | 393.89M | -8.07% | 2,092,528 | 92.62M |
| 256 | VTVT | vTv Therapeutics Inc. | 391.89M | -5.70% | 42,041 | 36.84M |
| 257 | LRMR | Larimar Therapeutics, Inc. | 388.83M | -12.97% | 2,297,804 | - |
| 258 | XFOR | X4 Pharmaceuticals, Inc. | 381.99M | -8.16% | 642,325 | 9.01M |
| 259 | AVIR | Atea Pharmaceuticals, Inc. | 379.33M | -5.01% | 193,976 | - |
| 260 | FENC | Fennec Pharmaceuticals Inc. | 373.42M | 2.48% | 327,042 | 51.00M |
| 261 | ANL | Adlai Nortye Ltd. | 369.60M | -6.38% | 234,217 | 5.00M |
| 262 | LXEO | Lexeo Therapeutics, Inc. | 364.73M | -3.63% | 584,284 | - |
| 263 | QTTB | Q32 Bio Inc. | 362.53M | 90.72% | 27,866,895 | 53.74M |
| 264 | VNDA | Vanda Pharmaceuticals Inc. | 360.81M | -3.85% | 1,168,135 | 217.78M |
| 265 | VCRE | Vicore Pharma Holding AB (publ) | 355.32M | -8.20% | 12,664 | 370.61K |
| 266 | FATE | Fate Therapeutics, Inc. | 352.01M | -2.58% | 6,046,348 | 6.32M |
| 267 | LYEL | Lyell Immunopharma, Inc. | 334.38M | -4.53% | 132,972 | 31.00K |
| 268 | IKT | Inhibikase Therapeutics, Inc. | 334.03M | -3.92% | 356,359 | 1.00 |
| 269 | IMRX | Immuneering Corporation | 333.84M | 0.98% | 703,794 | - |
| 270 | ZNTL | Zentalis Pharmaceuticals, Inc. | 328.88M | -5.33% | 1,172,896 | 26.87M |
| 271 | PALI | Palisade Bio, Inc. | 328.07M | -3.57% | 3,223,600 | - |
| 272 | FHTX | Foghorn Therapeutics Inc. | 319.40M | -8.57% | 286,010 | 28.22M |
| 273 | IRD | Opus Genetics, Inc. | 314.58M | -2.81% | 895,015 | 11.98M |
| 274 | OABI | OmniAb, Inc. | 305.89M | -7.86% | 416,093 | 28.94M |
| 275 | BCYC | Bicycle Therapeutics plc | 303.68M | -1.36% | 297,183 | 63.50M |
| 276 | IFRX | InflaRx N.V. | 303.42M | 0.49% | 1,720,617 | 33.82K |
| 277 | GALT | Galectin Therapeutics Inc. | 302.94M | 13.30% | 1,372,363 | - |
| 278 | LCTX | Lineage Cell Therapeutics, Inc. | 301.65M | -5.47% | 958,355 | 14.78M |
| 279 | ELDN | Eledon Pharmaceuticals, Inc. | 298.39M | 0.26% | 922,416 | - |
| 280 | INDP | Indaptus Therapeutics, Inc. | 297.83M | - | 40,237 | - |
| 281 | NMRA | Neumora Therapeutics, Inc. | 296.45M | -4.76% | 890,664 | - |
| 282 | MGNX | MacroGenics, Inc. | 286.03M | 3.93% | 1,124,151 | 157.08M |
| 283 | SABS | SAB Biotherapeutics, Inc. | 285.21M | -2.36% | 229,929 | 114.70K |
| 284 | TTRX | Turn Therapeutics Inc. | 282.09M | 0.32% | 207,859 | - |
| 285 | NAGE | Niagen Bioscience, Inc. | 276.95M | 2.36% | 1,105,846 | 130.42M |
| 286 | CNXU | Conexeu Sciences Inc. | 276.68M | 1.37% | 273,291 | - |
| 287 | GLSI | Greenwich LifeSciences, Inc. | 272.57M | -6.21% | 109,139 | - |
| 288 | ALXO | ALX Oncology Holdings Inc. | 265.09M | -7.29% | 1,216,873 | - |
| 289 | SRZN | Surrozen, Inc. | 264.83M | -1.64% | 336,596 | 7.49M |
| 290 | AGEN | Agenus Inc. | 254.85M | 82.69% | 174,271,454 | 123.87M |
| 291 | RNAC | Cartesian Therapeutics, Inc. | 253.56M | -8.77% | 259,948 | 1.78M |
| 292 | ADAG | Adagene Inc. | 252.40M | -3.05% | 263,171 | 7.67M |
| 293 | ACIU | AC Immune SA | 243.04M | 2.51% | 250,033 | 4.62M |
| 294 | SLGL | Sol-Gel Technologies Ltd. | 241.61M | -0.05% | 23,192 | 18.47M |
| 295 | PRQR | ProQR Therapeutics N.V. | 239.91M | -1.73% | 783,948 | 15.73M |
| 296 | TRDA | Entrada Therapeutics, Inc. | 237.82M | -4.62% | 284,674 | 5.74M |
| 297 | FULC | Fulcrum Therapeutics, Inc. | 235.88M | 1.14% | 1,721,383 | 80.00M |
| 298 | TARA | Protara Therapeutics, Inc. | 234.93M | -3.24% | 459,566 | - |
| 299 | CAMP | Camp4 Therapeutics Corporation | 233.67M | 3.93% | 108,129 | 3.93M |
| 300 | IVVD | Invivyd, Inc. | 232.00M | 0.52% | 2,451,477 | 55.87M |
| 301 | OBIO | Orchestra BioMed Holdings, Inc. | 228.74M | -4.26% | 218,293 | 32.72M |
| 302 | KPTI | Karyopharm Therapeutics Inc. | 227.76M | -2.80% | 431,397 | 151.12M |
| 303 | CHRS | Coherus Oncology, Inc. | 226.75M | -4.55% | 553,087 | 46.88M |
| 304 | NAUT | Nautilus Biotechnology, Inc. | 226.20M | -5.82% | 847,310 | - |
| 305 | DTIL | Precision BioSciences, Inc. | 221.64M | -1.94% | 707,965 | 45.07M |
| 306 | KROS | Keros Therapeutics, Inc. | 219.69M | -5.93% | 251,028 | 33.18M |
| 307 | AVXL | Anavex Life Sciences Corp. | 217.78M | -6.00% | 1,318,978 | - |
| 308 | CGEN | Compugen Ltd. | 217.54M | -3.77% | 234,626 | 72.66M |
| 309 | NBP | NovaBridge Biosciences | 215.11M | -2.11% | 427,601 | - |
| 310 | CLLS | Cellectis S.A. | 210.41M | -3.01% | 27,875 | 75.11M |
| 311 | RNA | Atrium Therapeutics, Inc. | 209.03M | -1.93% | 178,756 | 36.68M |
| 312 | WHWK | Whitehawk Therapeutics, Inc. | 206.53M | -3.27% | 507,052 | 7.15M |
| 313 | NGEN | NervGen Pharma Corp. | 204.97M | 2.66% | 1,122,996 | - |
| 314 | CDXS | Codexis, Inc. | 204.52M | -7.41% | 579,643 | 78.09M |
| 315 | NKTX | Nkarta, Inc. | 199.61M | -6.06% | 629,679 | - |
| 316 | IMUX | Immunic, Inc. | 199.42M | -0.88% | 251,844 | - |
| 317 | NERV | Minerva Neurosciences, Inc. | 198.93M | -9.53% | 160,753 | - |
| 318 | VYGR | Voyager Therapeutics, Inc. | 195.76M | -5.81% | 1,006,141 | 36.49M |
| 319 | KRRO | Korro Bio, Inc. | 194.70M | -7.28% | 193,480 | 3.84M |
| 320 | PLX | Protalix BioTherapeutics, Inc. | 192.57M | -2.05% | 534,967 | 76.38M |
| 321 | ARCT | Arcturus Therapeutics Holdings Inc. | 190.72M | -3.73% | 476,547 | 54.71M |
| 322 | ABOS | Acumen Pharmaceuticals, Inc. | 190.68M | 0.38% | 407,069 | - |
| 323 | OTLK | Outlook Therapeutics, Inc. | 187.34M | -1.27% | 8,791,706 | 333.14K |
| 324 | TNXP | Tonix Pharmaceuticals Holding Corp. | 186.59M | -6.58% | 1,029,387 | 17.56M |
| 325 | HUMA | Humacyte, Inc. | 186.37M | -0.36% | 7,649,719 | 2.02M |
| 326 | MDWD | MediWound Ltd. | 183.14M | -0.28% | 72,665 | 14.48M |
| 327 | ACOG | Alpha Cognition Inc. | 182.47M | -0.36% | 156,855 | 10.83M |
| 328 | EQ | Equillium, Inc. | 182.09M | -1.03% | 1,420,436 | 4.39M |
| 329 | TNYA | Tenaya Therapeutics, Inc. | 181.52M | -3.89% | 2,374,509 | 225.00K |
| 330 | CRBU | Caribou Biosciences, Inc. | 178.53M | -6.49% | 1,954,796 | 11.20M |
| 331 | CNTN | Canton Strategic Holdings, Inc. | 175.07M | -4.62% | 671,817 | - |
| 332 | MIST | Milestone Pharmaceuticals Inc. | 174.14M | - | 511,197 | 1.78M |
| 333 | NRXP | NRx Pharmaceuticals, Inc. | 173.93M | -0.95% | 817,748 | 2.29M |
| 334 | TLSA | Tiziana Life Sciences Ltd | 171.98M | 8.13% | 384,306 | - |
| 335 | IPHA | Innate Pharma S.A. | 171.59M | -0.17% | 11,980 | 10.57M |
| 336 | PEPG | PepGen Inc. | 168.77M | 4.27% | 2,359,323 | - |
| 337 | ALEC | Alector, Inc. | 167.65M | -6.21% | 775,930 | 18.42M |
| 338 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 167.49M | -6.61% | 362,753 | - |
| 339 | OKUR | OnKure Therapeutics, Inc. | 166.03M | -3.97% | 140,718 | - |
| 340 | MENS | Jyong Biotech Ltd. | 164.06M | - | 90,522 | - |
| 341 | LENZ | LENZ Therapeutics, Inc. | 163.98M | -6.44% | 1,525,746 | 20.99M |
| 342 | ANTX | AN2 Therapeutics, Inc. | 163.87M | 1.11% | 333,799 | - |
| 343 | CBUS | Cibus, Inc. | 162.59M | 5.45% | 1,073,091 | 4.29M |
| 344 | ORMP | Oramed Pharmaceuticals Inc. | 161.86M | -2.10% | 226,490 | 2.00M |
| 345 | KZIA | Kazia Therapeutics Limited | 155.29M | 0.22% | 122,253 | 1.27M |
| 346 | PYXS | Pyxis Oncology, Inc. | 154.59M | -8.61% | 942,808 | 13.86M |
| 347 | HURA | TuHURA Biosciences, Inc. | 151.56M | -0.42% | 770,300 | - |
| 348 | YDES | YD Bio Limited | 151.19M | -3.59% | 62,674 | 510.36K |
| 349 | MOLN | Molecular Partners AG | 146.84M | -0.35% | 1,363 | 856.30K |
| 350 | ARMP | Armata Pharmaceuticals, Inc. | 145.74M | -6.81% | 160,811 | 5.20M |
| 351 | CNTB | Connect Biopharma Holdings Limited | 142.30M | -9.96% | 485,749 | 233.00K |
| 352 | UNCY | Unicycive Therapeutics, Inc. | 135.90M | -2.30% | 1,175,660 | - |
| 353 | SPRB | Spruce Biosciences, Inc. | 133.16M | -3.38% | 103,676 | 697.00K |
| 354 | GNLX | Genelux Corporation | 131.45M | -2.31% | 187,498 | 8.00K |
| 355 | AARD | Aardvark Therapeutics, Inc. | 130.03M | -21.58% | 655,297 | - |
| 356 | CUE | Cue Biopharma, Inc. | 129.87M | -15.93% | 188,117 | 32.73M |
| 357 | SPRO | Spero Therapeutics, Inc. | 126.23M | 3.81% | 703,993 | 61.19M |
| 358 | ENGN | enGene Therapeutics Inc. | 124.60M | -2.11% | 1,049,153 | - |
| 359 | VANI | Vivani Medical, Inc. | 122.45M | 4.41% | 628,598 | - |
| 360 | GUTS | Fractyl Health, Inc. | 120.84M | -3.91% | 585,456 | 3.00K |
| 361 | SEER | Seer, Inc. | 119.31M | - | 365,096 | 15.17M |
| 362 | ALDX | Aldeyra Therapeutics, Inc. | 116.42M | -6.76% | 1,377,390 | - |
| 363 | PMN | ProMIS Neurosciences, Inc. | 114.79M | -10.18% | 75,812 | - |
| 364 | COYA | Coya Therapeutics, Inc. | 113.88M | -7.70% | 404,987 | 7.94M |
| 365 | NTHI | NeOnc Technologies Holdings, Inc. | 112.03M | -3.79% | 69,060 | 39.99K |
| 366 | ONCY | Oncolytics Biotech Inc. | 110.87M | 4.69% | 8,143,863 | - |
| 367 | FBIO | Fortress Biotech, Inc. | 109.62M | - | 863,056 | 66.16M |
| 368 | BDTX | Black Diamond Therapeutics, Inc. | 108.87M | -0.52% | 840,826 | 70.00M |
| 369 | ENLV | Enlivex Ltd. | 107.19M | -2.77% | 99,349 | - |
| 370 | KLRS | Kalaris Therapeutics, Inc. | 105.16M | -0.45% | 68,017 | - |
| 371 | PLYX | Polaryx Therapeutics, Inc. | 104.16M | -5.58% | 99,683 | - |
| 372 | ANIX | Anixa Biosciences, Inc. | 104.11M | - | 167,701 | - |
| 373 | VRCA | Verrica Pharmaceuticals Inc. | 101.70M | -5.43% | 13,819 | 37.16M |
| 374 | ICCC | ImmuCell Corporation | 100.24M | 1.74% | 29,488 | 29.93M |
| 375 | PYPD | PolyPid Ltd. | 96.64M | -3.63% | 254,572 | - |
| 376 | BMEA | Biomea Fusion, Inc. | 96.16M | 0.76% | 1,048,014 | - |
| 377 | ATHE | Alterity Therapeutics Limited | 95.83M | -0.92% | 5,198 | 4.43M |
| 378 | INO | Inovio Pharmaceuticals, Inc. | 95.44M | -1.69% | 1,122,966 | 65.34K |
| 379 | CRDF | Cardiff Oncology, Inc. | 92.30M | 1.50% | 727,567 | 525.00K |
| 380 | LONA | LeonaBio, Inc. | 91.68M | 1.67% | 315,936 | - |
| 381 | CGTX | Cognition Therapeutics, Inc. | 91.29M | -6.42% | 2,520,214 | - |
| 382 | PTHS | Pelthos Therapeutics Inc. | 91.24M | -1.13% | 42,473 | 27.70M |
| 383 | ACET | Adicet Bio, Inc. | 89.78M | -3.17% | 116,335 | - |
| 384 | MAIA | MAIA Biotechnology, Inc. | 86.34M | -1.39% | 1,130,225 | - |
| 385 | TELO | Telomir Pharmaceuticals, Inc. | 85.28M | 0.81% | 35,690 | - |
| 386 | NRXS | NeurAxis, Inc. | 85.20M | -3.64% | 105,703 | 4.28M |
| 387 | ACRV | Acrivon Therapeutics, Inc. | 84.75M | 1.02% | 1,105,658 | - |
| 388 | RNTX | Rein Therapeutics Inc. | 84.43M | -7.40% | 644,632 | - |
| 389 | RLYB | Rallybio Corporation | 84.19M | 1.02% | 125,311 | 858.00K |
| 390 | ALPS | Alps Group Inc | 83.38M | -9.11% | 111,915 | 3.74M |
| 391 | OKYO | OKYO Pharma Limited | 81.34M | -8.28% | 201,273 | - |
| 392 | ENTX | Entera Bio Ltd. | 80.84M | -0.91% | 81,777 | 42.00K |
| 393 | CSBR | Champions Oncology, Inc. | 80.68M | -0.17% | 3,493 | 57.95M |
| 394 | HRTX | Heron Therapeutics, Inc. | 78.91M | 0.60% | 6,180,285 | 150.71M |
| 395 | RANI | Rani Therapeutics Holdings, Inc. | 78.37M | -7.95% | 1,118,391 | 3.17M |
| 396 | ATRA | Atara Biotherapeutics, Inc. | 78.12M | -11.17% | 136,328 | 23.14M |
| 397 | GANX | Gain Therapeutics, Inc. | 75.07M | -2.22% | 997,358 | - |
| 398 | ANVS | Annovis Bio, Inc. | 74.87M | -5.38% | 969,196 | - |
| 399 | OSTX | OS Therapies Incorporated | 72.15M | -3.57% | 636,227 | - |
| 400 | IBIO | iBio, Inc. | 72.03M | -3.97% | 1,076,544 | 300.00K |
| 401 | XBIT | XBiotech Inc. | 71.04M | 1.75% | 78,790 | - |
| 402 | GOSS | Gossamer Bio, Inc. | 70.44M | -15.09% | 30,798,232 | 55.54M |
| 403 | PLRX | Pliant Therapeutics, Inc. | 70.05M | 1.79% | 1,219,357 | - |
| 404 | HYFT | MindWalk Holdings Corp. | 70.03M | -1.40% | 155,698 | 20.70M |
| 405 | IMA | ImageneBio, Inc. | 68.92M | 3.38% | 12,583 | 800.00K |
| 406 | PMVP | PMV Pharmaceuticals, Inc. | 68.26M | 3.23% | 889,704 | - |
| 407 | TCRX | TScan Therapeutics, Inc. | 67.31M | -5.50% | 1,152,399 | 9.14M |
| 408 | MNOV | MediciNova, Inc. | 66.94M | -2.16% | 14,723 | 596.64K |
| 409 | CING | Cingulate Inc. | 63.04M | -4.68% | 345,942 | - |
| 410 | ELTX | Elicio Therapeutics, Inc. | 62.75M | -5.46% | 493,446 | - |
| 411 | EDSA | Edesa Biotech, Inc. | 60.55M | -2.85% | 37,891 | - |
| 412 | CNTX | Context Therapeutics Inc. | 57.31M | -4.46% | 3,438,223 | - |
| 413 | IMMP | Immutep Limited | 57.26M | 7.52% | 460,916 | 5.28M |
| 414 | FLNA | Filana Therapeutics, Inc. | 55.55M | -2.54% | 306,459 | - |
| 415 | INKT | MiNK Therapeutics, Inc. | 55.55M | 0.90% | 10,507 | - |
| 416 | XLO | Xilio Therapeutics, Inc. | 55.28M | 1.54% | 71,451 | 53.48M |
| 417 | BOLD | Boundless Bio, Inc. | 54.81M | 1.24% | 310,292 | - |
| 418 | BYSI | BeyondSpring Inc. | 54.69M | -7.64% | 37,500 | 1.88M |
| 419 | MCRB | Seres Therapeutics, Inc. | 54.42M | -8.02% | 333,528 | 1.15M |
| 420 | EXOZ | eXoZymes, Inc. | 54.01M | -8.61% | 12,932 | -700.00 |
| 421 | VRXA | Veraxa Biotech AG | 53.97M | -2.73% | 556,891 | - |
| 422 | TIL | Instil Bio, Inc. | 51.81M | -0.78% | 27,575 | - |
| 423 | MREO | Mereo BioPharma Group plc | 51.24M | -4.18% | 742,639 | 500.00K |
| 424 | IBO | Impact BioMedical Inc. | 49.92M | 4.75% | 37,638 | 39.00K |
| 425 | MGX | Metagenomi Therapeutics, Inc. | 49.69M | 3.94% | 372,380 | 22.33M |
| 426 | INMB | INmune Bio Inc. | 49.45M | -4.12% | 1,077,811 | 50.00K |
| 427 | ATYR | aTyr Pharma, Inc. | 49.43M | -7.40% | 797,821 | 190.00K |
| 428 | RADX | Radiopharm Theranostics Limited | 49.18M | -0.92% | 8,283 | 10.86M |
| 429 | DWTX | Dogwood Therapeutics, Inc. | 46.41M | -2.82% | 41,266 | - |
| 430 | ELOX | Eloxx Pharmaceuticals, Inc. | 45.81M | -3.90% | 40,320 | - |
| 431 | HYPD | Hyperion DeFi, Inc. | 45.02M | -3.88% | 168,829 | 1.04M |
| 432 | CRVO | CervoMed Inc. | 44.77M | -7.28% | 1,399,422 | 2.09M |
| 433 | LTRN | Lantern Pharma Inc. | 44.15M | -3.89% | 135,817 | - |
| 434 | PDSB | PDS Biotechnology Corporation | 41.59M | -3.71% | 324,136 | - |
| 435 | RNXT | RenovoRx, Inc. | 41.19M | -1.80% | 169,900 | 1.49M |
| 436 | VERU | Veru Inc. | 41.09M | -7.91% | 397,912 | 16.89M |
| 437 | GRCE | Grace Therapeutics, Inc. | 39.55M | -0.82% | 116,772 | - |
| 438 | ALGS | Aligos Therapeutics, Inc. | 39.36M | -3.93% | 189,230 | 4.71M |
| 439 | ESLA | Estrella Immunopharma, Inc. | 37.68M | -5.53% | 21,983 | - |
| 440 | NNVC | NanoViricides, Inc. | 37.59M | 9.27% | 816,731 | - |
| 441 | DYAI | Dyadic International, Inc. | 37.17M | -3.77% | 218,317 | 3.81M |
| 442 | ACTU | Actuate Therapeutics, Inc. | 35.89M | 23.97% | 2,686,663 | - |
| 443 | NTRB | Nutriband Inc. | 35.74M | -0.68% | 6,918 | 1.80M |
| 444 | BCTX | BriaCell Therapeutics Corp. | 34.33M | -4.82% | 218,148 | - |
| 445 | ABVC | ABVC BioPharma, Inc. | 34.11M | -10.60% | 169,320 | 797.92K |
| 446 | LSTA | Lisata Therapeutics, Inc. | 33.69M | 13.15% | 165,931 | 170.00K |
| 447 | LITS | Lite Strategy, Inc. | 32.18M | -6.36% | 307,990 | - |
| 448 | DARE | Daré Bioscience, Inc. | 31.31M | 3.47% | 158,515 | 1.16M |
| 449 | APLM | Apollomics, Inc. | 31.21M | -25.01% | 141,584 | 8.84M |
| 450 | GNTA | Genenta Science S.p.A. | 31.14M | -12.00% | 95,437 | - |
| 451 | TVRD | Tvardi Therapeutics, Inc. | 31.05M | 0.91% | 2,241,963 | - |
| 452 | SER | Serina Therapeutics, Inc. | 30.74M | -4.21% | 37,680 | 130.00K |
| 453 | SNTI | Senti Biosciences Holdings, Inc. | 29.90M | -6.80% | 103,268 | 38.00K |
| 454 | KYNB | Kyntra Bio, Inc. | 29.73M | -3.48% | 13,709 | 7.44M |
| 455 | PSTV | Plus Therapeutics, Inc. | 28.70M | 4.25% | 374,909 | 5.18M |
| 456 | ATNM | Actinium Pharmaceuticals, Inc. | 28.39M | -2.69% | 96,428 | 90.00K |
| 457 | GRDX | GridAI Technologies Corp. | 27.08M | -9.56% | 31,099 | - |
| 458 | IGC | IGC Pharma, Inc. | 26.61M | -2.24% | 512,204 | 1.11M |
| 459 | PLRZ | Polyrizon Ltd. | 25.94M | -5.39% | 30,246 | - |
| 460 | NRSN | NeuroSense Therapeutics Ltd. | 25.81M | 0.21% | 71,387 | - |
| 461 | EVAX | Evaxion A/S | 25.19M | -4.73% | 14,525 | 7.53M |
| 462 | BRNS | Barinthus Biotherapeutics plc | 24.92M | -4.36% | 68,193 | 14.97M |
| 463 | MRKR | Marker Therapeutics, Inc. | 24.34M | -3.31% | 34,639 | 3.55M |
| 464 | AKTX | Akari Therapeutics, Plc | 23.46M | -3.46% | 89,974 | - |
| 465 | SKYE | Skye Bioscience, Inc. | 23.27M | -4.06% | 210,880 | - |
| 466 | VYNE | VYNE Therapeutics Inc. | 21.94M | 3.18% | 2,951,990 | 454.00K |
| 467 | CELU | Celularity Inc. | 21.86M | 1.99% | 57,869 | 26.55M |
| 468 | QNTM | Quantum BioPharma Ltd. | 21.54M | 6.65% | 63,703 | - |
| 469 | NCEL | NewcelX Ltd. | 21.54M | -4.53% | 20,423 | - |
| 470 | CVM | CEL-SCI Corporation | 21.32M | -11.59% | 443,036 | - |
| 471 | CLRB | Cellectar Biosciences, Inc. | 21.02M | -6.74% | 133,356 | - |
| 472 | TVGN | Tevogen Bio Holdings Inc. | 20.94M | -1.19% | 14,753 | - |
| 473 | ATOS | Atossa Therapeutics, Inc. | 20.67M | 1.27% | 177,554 | - |
| 474 | KALA | KALA BIO, Inc. | 20.26M | -7.23% | 211,991 | - |
| 475 | LGVN | Longeveron Inc. | 19.94M | -6.52% | 448,994 | 1.22M |
| 476 | LPCN | Lipocine Inc. | 19.37M | -2.49% | 37,222 | 2.00M |
| 477 | ICU | SeaStar Medical Holding Corporation | 19.26M | -3.23% | 49,304 | 1.44M |
| 478 | NEUP | Neuphoria Therapeutics Inc. | 18.86M | -1.41% | 44,925 | -13.27K |
| 479 | ALLR | Allarity Therapeutics, Inc. | 17.98M | -3.00% | 69,753 | 345.00K |
| 480 | PLUR | Pluri Inc. | 17.59M | -4.96% | 50,262 | 1.08M |
| 481 | PTN | Palatin Technologies, Inc. | 17.24M | -4.80% | 8,554 | 12.88M |
| 482 | JSPR | Jasper Therapeutics, Inc. | 17.02M | 4.90% | 1,348,425 | - |
| 483 | QNCX | Quince Therapeutics, Inc. | 16.87M | -1.65% | 52,671 | - |
| 484 | HOWL | Werewolf Therapeutics, Inc. | 16.60M | -15.26% | 1,052,070 | 1.14M |
| 485 | KTTA | Pasithea Therapeutics Corp. | 16.37M | -0.49% | 403,019 | - |
| 486 | CYCN | Cyclerion Therapeutics, Inc. | 16.20M | -0.39% | 11,655 | 1.99M |
| 487 | HIND | Vyome Holdings, Inc. | 15.72M | -0.44% | 15,205 | 152.72K |
| 488 | MLEC | Moolec Science SA | 15.44M | 1.26% | 4,239 | 7.83M |
| 489 | CTXR | Citius Pharmaceuticals, Inc. | 14.82M | -7.33% | 258,054 | 5.61M |
| 490 | LEXX | Lexaria Bioscience Corp. | 14.75M | -8.00% | 62,676 | 368.00K |
| 491 | TPST | Tempest Therapeutics, Inc. | 14.56M | 1.08% | 450,718 | - |
| 492 | PASG | Passage Bio, Inc. | 14.31M | -2.41% | 94,938 | - |
| 493 | GTBP | GT Biopharma, Inc. | 13.98M | -8.78% | 1,720,504 | - |
| 494 | INTS | Intensity Therapeutics, Inc. | 13.30M | 2.93% | 46,155 | - |
| 495 | COCP | Cocrystal Pharma, Inc. | 13.24M | -4.95% | 27,891 | 225.00K |
| 496 | INAB | IN8bio, Inc. | 13.20M | 0.75% | 76,142 | - |
| 497 | BLRX | BioLineRx Ltd. | 13.00M | 0.32% | 12,594 | 1.40M |
| 498 | CALC | CalciMedica, Inc. | 12.92M | -12.06% | 575,303 | - |
| 499 | LNAI | Lunai Bioworks Inc. | 12.83M | -3.74% | 37,324 | 20.94K |
| 500 | OSRH | OSR Health, Inc. | 12.50M | 8.40% | 2,115,189 | 2.63M |